The 13th five-year plan for science and technology innovation in traditional Chinese medicine: the establishment of a collaborative, efficient and open scientific and technological innovation system

From the author:

Recently, the ministry of science and technology and the state administration of traditional Chinese medicine jointly issued the "much starker choices-and graver consequences-in" special planning, science and technology innovation of traditional Chinese medicine, put forward to 2020, a more collaborative, efficient, open Chinese medicine science and technology innovation system, to solve a number of key scientific problems which restrict the development of the traditional Chinese medicine, through a number of key core technologies in the development of TCM, accelerating the modernization and internationalization of TCM, build more accord with the characteristics of inheritance and innovation of traditional Chinese medicine research model and the technical system, significantly enhance the capacity of scientific and technological innovation of Chinese medicine, further enhance the ability of prevention and control of major refractory disease of traditional Chinese medicine and the cure not ill.

Planning clear, inheritance, enrich and develop TCM theory system, perfecting the innovation platform of science and technology of Chinese medicine, system arrangement, mining and inheriting 100 well-known Chinese medicine expert academic experience, the construction of 1500 kinds of basic ancient documents of Chinese medicine digital and resource information database; We will improve the effectiveness of 8 ~ 10 major diseases and 3 ~ 5 diseases of the disease, and develop a number of treatments for the treatment of undeveloped diseases and promote the use of the disease. Improving the level of Chinese traditional Chinese medicine and its capacity for research and development; Improve the international standard of traditional Chinese medicine, form of not less than 50 100 pharmacopoeia standards and industry standards, complete 5 ~ 10 varieties of proprietary Chinese medicine as a drug registration in Europe and the United States and other developed countries, set up a batch of research center of traditional Chinese medicine and joint laboratory, to strengthen the cooperation of countries along the "area"; Technical standards set a number of national characteristic medical diagnosis and treatment techniques, build 10 ~ 15 kinds of national medical plan and guide the clinical diagnosis and treatment, establish national medicine resources database, national drug safety, efficacy evaluation platform, etc.

Planning key technology and innovation methods, puts forward the development of frontier deepen the theory of traditional Chinese medicine inheritance and innovation, enhance the level of major disease prevention and control of traditional Chinese medicine, the development of traditional Chinese medicine health service technology, promote the protection of traditional Chinese medicine resources and value enhancement, strengthening Chinese traditional medicine research and development technology and product development, promote the standardization and internationalization of traditional Chinese medicine, strengthen national medicine inheritance and innovation, and building a supporting system for the innovation of traditional Chinese medicine network and nine key tasks, key technology and cutting-edge innovation methods, such as name old doctor of traditional Chinese medicine experience study of 31 column.

It is required to strengthen the cross-fusion of the cutting-edge technologies of system biology, big data, artificial intelligence and other disciplines of traditional Chinese medicine. Build and publish the list of traditional knowledge protection of traditional Chinese medicine database, focusing on the holder (body) protection, protecting sources disclosed, benefit sharing for such key problems, promote the establishment of traditional Chinese medicine in the framework of the intellectual property system as a whole in traditional knowledge protection system. Completed 6 ~ 8 major disease with TCM, mature scheme of large sample multi-center clinical research, set up 6 ~ 8 evidence-based guidelines for prevention and control of major diseases of traditional Chinese medicine, to elucidate the curative effect mechanism, and into the higher level of clinical guidelines. Around the health status of traditional Chinese medicine identification evaluation, disease risk forecast warning, health interventions such as cure not ill key step of core technology, draw lessons from the achievements of modern life science, biomedical, make full use of informatics, big data, such as the Internet technology, the ability and level of ascension healing without disease. Based on the fourth national census of traditional Chinese medicine, the information level of Chinese traditional Chinese medicine and the protection of germplasm resources were comprehensively promoted. Clear 200 ~ 300 kinds of commonly used traditional Chinese medicine (TCM) potential toxic substance and mechanism, establishing database of potentially toxic substances, in 50 ~ 70 species of toxic traditional Chinese medicines commonly used safety evaluation in the process of research and development of new drug research, carried out 30 ~ 50 kinds of commonly used traditional Chinese medicine (TCM) injections of sensitization material screening, identification, control and risk assessment.

To ensure the implementation, planning and puts forward the overall coordination, diversified investment, perfect policy, constructing system, talent cultivation, discipline integration three measures, their quest to establish a diversified investment of science and technology of Chinese medicine channels, guide the local government, enterprises, institutions, such as various power increase investment in scientific research. We will improve the examination and approval standards and management measures for new drugs that conform to the characteristics and regulations of traditional Chinese medicine. Based on knowledge value, scientific research ability, innovation and application development as the guidance of the scientific and technological personnel evaluation standard diversification, perfect the income distribution incentive mechanism transformation of scientific and technological achievements, encouraging science and technology personnel of Chinese medicine business, and improve the mechanism of scientific research talents bidirectional flow, etc.

Wen: Chinese traditional Chinese medicine reporter zhao weiting